Considerations in the evaluation and management of oral potentially malignant disorders during the COVID-19 pandemic.
Rabie M ShantiEric T StooplerGregory S WeinsteinJason G NewmanSteven B CannadyKarthik RajasekaranTakako I TanakaBert W O'MalleyAnh D LeThomas P SollecitoPublished in: Head & neck (2020)
The COVID-19 pandemic has required health care practitioners to make novel decisions that are new to us with development of creative pathways of care that focused on patient safety, mitigation efforts, and clinical management of disease processes. The care of patients with OPMDs requires special considerations especially as patients at high risk for severe COVID-19 illness are also higher risk for the development of OPMDs.
Keyphrases
- patient safety
- quality improvement
- healthcare
- end stage renal disease
- palliative care
- coronavirus disease
- chronic kidney disease
- sars cov
- newly diagnosed
- ejection fraction
- primary care
- prognostic factors
- affordable care act
- climate change
- pain management
- early onset
- patient reported outcomes
- general practice
- respiratory syndrome coronavirus